p.86 抽出テキスト

322. Bing R, Cavalcante JL, Everett RJ, Clavel MA, Newby DE, Dweck MR. Imaging and impact of myocardial fibrosis in aortic stenosis. JACC Cardiovasc Imaging 2019;12:283–96. https://doi.org/10.1016/j.jcmg.2018.11.026 323. Everett RJ, Treibel TA, Fukui M, Lee H, Rigolli M, Singh A, et al. Extracellular myocardial volume in patients with aortic stenosis. J Am Coll Cardiol 2020;75:304–16. https://doi. org/10.1016/j.jacc.2019.11.032 324. Thornton GD, Vassiliou VS, Musa TA, Aziminia N, Craig N, Dattani A, et al. Myocardial scar and remodelling predict long-term mortality in severe aortic stenosis beyond 10 years. Eur Heart J 2024;45:2019–22. https://doi.org/10.1093/eurheartj/ehae067 325. Nitsche C, Scully PR, Patel KP, Kammerlander AA, Koschutnik M, Dona C, et al. Prevalence and outcomes of concomitant aortic stenosis and cardiac amyloidosis. J Am Coll Cardiol 2021;77:128–39. https://doi.org/10.1016/j.jacc.2020.11.006 326. Maurer MS, Bokhari S, Damy T, Dorbala S, Drachman BM, Fontana M, et al. Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis. Circ Heart Fail 2019;12:e006075. https://doi.org/10.1161/circheartfailure. 119.006075 327. Cannata F, Chiarito M, Pinto G, Villaschi A, Sanz-Sánchez J, Fazzari F, et al. Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic review and meta-analysis. ESC Heart Fail 2022;9:3188–97. https://doi.org/ 10.1002/ehf2.13876 328. Blanke P, Weir-McCall JR, Achenbach S, Delgado V, Hausleiter J, Jilaihawi H, et al. Computed tomography imaging in the context of Transcatheter Aortic Valve Implantation (TAVI)/Transcatheter Aortic Valve Replacement (TAVR). JACC Cardiovasc Imaging 2019;12:1–24. https://doi.org/10.1016/j.jcmg.2018.12.003 329. Khan JM, Kamioka N, Lisko JC, Perdoncin E, Zhang C, Maini A, et al. Coronary obstruction from TAVR in native aortic stenosis: development and validation of multivariate prediction model. JACC Cardiovasc Interv 2023;16:415–25. https://doi.org/10.1016/j. jcin.2022.11.018 330. Reindl M, Lechner I, Holzknecht M, Tiller C, Fink P, Oberhollenzer F, et al. Cardiac magnetic resonance imaging versus computed tomography to guide transcatheter aortic valve replacement: a randomized, open-label, noninferiority trial. Circulation 2023; 148:1220–30. https://doi.org/10.1161/CIRCULATIONAHA.123.066498 331. Gleitman S, Elbaz-Greener G, Ghanim D, Kusniec F, Rabin A, Sudarsky D, et al. Similar procedural success of transcutaneous aortic valve replacement with prosthesis valve sizing by either three-dimensional transesophageal echocardiography modeling or computed tomography. J Am Soc Echocardiogr 2020;33:1149–51. https://doi.org/10. 1016/j.echo.2020.05.026 332. Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 2008;359: 1343–56. https://doi.org/10.1056/NEJMoa0804602 333. Cowell SJ, Newby DE, Prescott RJ, Bloomfield P, Reid J, Northridge DB, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005;352:2389–97. https://doi.org/10.1056/NEJMoa043876 334. Chan KL, Teo K, Dumesnil JG, Ni A, Tam J. Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation 2010;121: 306–14. https://doi.org/10.1161/CIRCULATIONAHA.109.900027 335. Pawade TA, Doris MK, Bing R, White AC, Forsyth L, Evans E, et al. Effect of denosumab or alendronic acid on the progression of aortic stenosis: a double-blind randomized controlled trial. Circulation 2021;143:2418–27. https://doi.org/10.1161/CIRCU LATIONAHA.121.053708 336. Diederichsen ACP, Lindholt JS, Möller S, Øvrehus KA, Auscher S, Lambrechtsen J, et al. Vitamin K2 and D in patients with aortic valve calcification: a randomized doubleblinded clinical trial. Circulation 2022;145:1387–97. https://doi.org/10.1161/ CIRCULATIONAHA.121.057008 337. McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J 2024;45:3912–4018. https://doi.org/10.1093/eurheartj/ehae178 338. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2021; 42:3227–337. https://doi.org/10.1093/eurheartj/ehab484 339. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2021;42:3599–726. https://doi.org/10.1093/eurheartj/ehab368 340. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2023 Focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2023;44:3627–39. https://doi.org/10.1093/eurheartj/ehad195 341. Monin JL, Quéré JP, Monchi M, Petit H, Baleynaud S, Chauvel C, et al. Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation 2003;108: 319–24. https://doi.org/10.1161/01.CIR.0000079171.43055.46 342. Tribouilloy C, Levy F, Rusinaru D, Gueret P, Petit-Eisenmann H, Baleynaud S, et al. Outcome after aortic valve replacement for low-flow/low-gradient aortic stenosis without contractile reserve on dobutamine stress echocardiography. J Am Coll Cardiol 2009;53:1865–73. https://doi.org/10.1016/j.jacc.2009.02.026 343. Quere JP, Monin JL, Levy F, Petit H, Baleynaud S, Chauvel C, et al. Influence of preoperative left ventricular contractile reserve on postoperative ejection fraction in lowgradient aortic stenosis. Circulation 2006;113:1738–44. https://doi.org/10.1161/ circulationaha.105.568824 344. Fougeres E, Tribouilloy C, Monchi M, Petit-Eisenmann H, Baleynaud S, Pasquet A, et al. Outcomes of pseudo-severe aortic stenosis under conservative treatment. Eur Heart J 2012;33:2426–33. https://doi.org/10.1093/eurheartj/ehs176 345. Levy F, Laurent M, Monin JL, Maillet JM, Pasquet A, Le Tourneau T, et al. Aortic valve replacement for low-flow/low-gradient aortic stenosis operative risk stratification and long-term outcome: a European multicenter study. J Am Coll Cardiol 2008;51:1466–72. https://doi.org/10.1016/j.jacc.2007.10.067 346. Maes F, Lerakis S, Barbosa Ribeiro H, Gilard M, Cavalcante JL, Makkar R, et al. Outcomes from transcatheter aortic valve replacement in patients with low-flow, lowgradient aortic stenosis and left ventricular ejection fraction less than 30%: a substudy from the TOPAS-TAVI registry. JAMA Cardiol 2019;4:64–70. https://doi.org/10.1001/ jamacardio.2018.4320 347. Sato K, Sankaramangalam K, Kandregula K, Bullen JA, Kapadia SR, Krishnaswamy A, et al. Contemporary outcomes in low-gradient aortic stenosis patients who underwent dobutamine stress echocardiography. J Am Heart Assoc 2019;8:e011168. https://doi.org/10.1161/JAHA.118.011168 348. Ueyama H, Kuno T, Harrington M, Takagi H, Krishnamoorthy P, Sharma SK, et al. Impact of surgical and transcatheter aortic valve replacement in low-gradient aortic stenosis: a meta-analysis. JACC Cardiovasc Interv 2021;14:1481–92. https://doi.org/10. 1016/j.jcin.2021.04.038 349. Clavel MA, Dumesnil JG, Capoulade R, Mathieu P, Senechal M, Pibarot P. Outcome of patients with aortic stenosis, small valve area, and low-flow, low-gradient despite preserved left ventricular ejection fraction. J Am Coll Cardiol 2012;60:1259–67. https://doi. org/10.1016/j.jacc.2011.12.054 350. Chadha G, Bohbot Y, Rusinaru D, Marechaux S, Tribouilloy C. Outcome of normalflow low-gradient severe aortic stenosis with preserved left ventricular ejection fraction: a propensity-matched study. J Am Heart Assoc 2019;8:e012301. https://doi.org/10. 1161/JAHA.119.012301 351. Pellikka PA, Sarano ME, Nishimura RA, Malouf JF, Bailey KR, Scott CG, et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 2005;111:3290–5. https://doi.org/10.1161/ circulationaha.104.495903 352. Heuvelman HJ, van Geldorp MW, Kappetein AP, Geleijnse ML, Galema TW, Bogers AJ, et al. Clinical course of patients diagnosed with severe aortic stenosis in the Rotterdam area: insights from the AVARIJN study. Neth Heart J 2012;20:487–93. https://doi.org/ 10.1007/s12471-012-0309-3 353. Otto CM, Burwash IG, Legget ME, Munt BI, Fujioka M, Healy NL, et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation 1997;95:2262–70. https://doi.org/10.1161/01. cir.95.9.2262 354. Bohbot Y, de Meester de Ravenstein C, Chadha G, Rusinaru D, Belkhir K, Trouillet C, et al. Relationship between left ventricular ejection fraction and mortality in asymptomatic and minimally symptomatic patients with severe aortic stenosis. JACC Cardiovasc Imaging 2019;12:38–48. https://doi.org/10.1016/j.jcmg.2018.07.029 355. Capoulade R, Le Ven F, Clavel MA, Dumesnil JG, Dahou A, Thebault C, et al. Echocardiographic predictors of outcomes in adults with aortic stenosis. Heart 2016;102:934–42. https://doi.org/10.1136/heartjnl-2015-308742 356. Dahl JS, Eleid MF, Michelena HI, Scott CG, Suri RM, Schaff HV, et al. Effect of left ventricular ejection fraction on postoperative outcome in patients with severe aortic stenosis undergoing aortic valve replacement. Circ Cardiovasc Imaging 2015;8:e002917. https://doi.org/10.1161/CIRCIMAGING.114.002917 357. Taniguchi T, Morimoto T, Shiomi H, Ando K, Kanamori N, Murata K, et al. Prognostic impact of left ventricular ejection fraction in patients with severe aortic stenosis. JACC Cardiovasc Interv 2018;11:145–57. https://doi.org/10.1016/j.jcin.2017.08.036 358. Ito S, Miranda WR, Nkomo VT, Connolly HM, Pislaru SV, Greason KL, et al. Reduced left ventricular ejection fraction in patients with aortic stenosis. J Am Coll Cardiol 2018; 71:1313–21. https://doi.org/10.1016/j.jacc.2018.01.045 359. De Azevedo D, Boute M, Tribouilloy C, Maréchaux S, Pouleur AC, Bohbot Y, et al. Quantifying the survival loss linked to late therapeutic indication in high-gradient severe aortic stenosis. JACC Adv 2024;3:100830. https://doi.org/10.1016/j.jacadv.2024. 100830 360. Généreux P, Schwartz A, Oldemeyer JB, Pibarot P, Cohen DJ, Blanke P, et al. Transcatheter aortic-valve replacement for asymptomatic severe aortic stenosis. N Engl J Med 2024;392:217–27. https://doi.org/10.1056/NEJMoa2405880 361. Loganath K, Craig NJ, Everett RJ, Bing R, Tsampasian V, Molek P, et al. Early intervention in patients with asymptomatic severe aortic stenosis and myocardial fibrosis: the Downloaded from academic.oup.com/eurheartj/article/46/44/4635/8234488 by guest on 07 October 2026